| Identification | Back Directory | [Name]
ipramidil | [CAS]
83656-38-6 | [Synonyms]
C80-1324
ipramidil
N,N'-Bis(1-methylethyl)furazan-3,4-dicarboxamide 2-oxide
3,4-Bis[(isopropylamino)carbonyl]-1,2,5-oxadiazole 2-oxide
1,2,5-Oxadiazole-3,4-dicarboxamide, N3,N4-bis(1-methylethyl)-, 2-oxide | [EINECS(EC#)]
280-511-5 | [Molecular Formula]
C10H16N4O4 | [MDL Number]
MFCD00869092 | [MOL File]
83656-38-6.mol | [Molecular Weight]
256.26 |
| Chemical Properties | Back Directory | [density ]
1.38±0.1 g/cm3(Predicted) | [storage temp. ]
Store at -20°C | [solubility ]
Soluble in DMSO | [form ]
Solid | [pka]
11.92±0.46(Predicted) | [color ]
Off-white to light yellow |
| Hazard Information | Back Directory | [Uses]
Ipramidil (C80-1324) is a vasodilator with significant active dilation of coronary circulation in isolated hearts. Ipramidil can cause an increase in NO release and stimulate guanylate cyclase activity. | [References]
[1] Feelisch M, et al. Thiol-mediated generation of nitric oxide accounts for the vasodilator action of furoxans. Biochem Pharmacol. 1992 Sep 25;44(6):1149-57. DOI:10.1016/0006-2952(92)90379-w
[2] Feelisch M, et al. Thiol-mediated generation of nitric oxide accounts for the vasodilator action of furoxans. Biochem Pharmacol. 1992 Sep 25;44(6):1149-57. DOI:10.1016/0006-2952(92)90379-w |
|
|